Logo image of MB.MI

MEDIOBANCA SPA (MB.MI) Stock Fundamental Analysis

BIT:MB - Euronext Milan - IT0000062957 - Common Stock - Currency: EUR

18.405  +0.2 (+1.07%)

Fundamental Rating

3

Overall MB gets a fundamental rating of 3 out of 10. We evaluated MB against 95 industry peers in the Banks industry. While MB is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, MB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MB was profitable.
In the past year MB has reported a negative cash flow from operations.
In the past 5 years MB has always been profitable.
In multiple years MB reported negative operating cash flow during the last 5 years.
MB.MI Yearly Net Income VS EBIT VS OCF VS FCFMB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

MB has a Return On Assets of 1.99%. This is amongst the best in the industry. MB outperforms 94.74% of its industry peers.
MB's Return On Equity of 17.68% is amongst the best of the industry. MB outperforms 90.53% of its industry peers.
Industry RankSector Rank
ROA 1.99%
ROE 17.68%
ROIC N/A
ROA(3y)1.14%
ROA(5y)1.03%
ROE(3y)9.67%
ROE(5y)8.51%
ROIC(3y)N/A
ROIC(5y)N/A
MB.MI Yearly ROA, ROE, ROICMB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With an excellent Profit Margin value of 34.24%, MB belongs to the best of the industry, outperforming 88.42% of the companies in the same industry.
MB's Profit Margin has been stable in the last couple of years.
MB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 34.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.77%
PM growth 5Y1.38%
GM growth 3YN/A
GM growth 5YN/A
MB.MI Yearly Profit, Operating, Gross MarginsMB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

MB does not have a ROIC to compare to the WACC, probably because it is not profitable.
MB has less shares outstanding than it did 1 year ago.
MB has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MB has a worse debt to assets ratio.
MB.MI Yearly Shares OutstandingMB.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
MB.MI Yearly Total Debt VS Total AssetsMB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

A Debt/Equity ratio of 4.11 is on the high side and indicates that MB has dependencies on debt financing.
The Debt to Equity ratio of MB (4.11) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.11
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.39%
MB.MI Yearly LT Debt VS Equity VS FCFMB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MB.MI Yearly Current Assets VS Current LiabilitesMB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

MB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.58%, which is quite impressive.
Measured over the past years, MB shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.21% on average per year.
The Revenue has grown by 11.75% in the past year. This is quite good.
MB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.64% yearly.
EPS 1Y (TTM)21.58%
EPS 3Y18.01%
EPS 5Y10.21%
EPS Q2Q%33.33%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y11.09%
Revenue growth 5Y7.64%
Sales Q2Q%13.4%

3.2 Future

MB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.51% yearly.
The Revenue is expected to grow by 2.63% on average over the next years.
EPS Next Y7.14%
EPS Next 2Y7.17%
EPS Next 3Y6.02%
EPS Next 5Y4.51%
Revenue Next Year3.58%
Revenue Next 2Y3.9%
Revenue Next 3Y4.01%
Revenue Next 5Y2.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MB.MI Yearly Revenue VS EstimatesMB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
MB.MI Yearly EPS VS EstimatesMB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.43 indicates a reasonable valuation of MB.
Based on the Price/Earnings ratio, MB is valued a bit more expensive than the industry average as 75.79% of the companies are valued more cheaply.
MB is valuated cheaply when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.36 indicates a reasonable valuation of MB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MB is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 20.81. MB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.43
Fwd PE 10.36
MB.MI Price Earnings VS Forward Price EarningsMB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MB.MI Per share dataMB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.6
PEG (5Y)1.12
EPS Next 2Y7.17%
EPS Next 3Y6.02%

6

5. Dividend

5.1 Amount

MB has a Yearly Dividend Yield of 5.95%, which is a nice return.
MB's Dividend Yield is comparable with the industry average which is at 5.30.
Compared to an average S&P500 Dividend Yield of 2.45, MB pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.95%

5.2 History

On average, the dividend of MB grows each year by 24.10%, which is quite nice.
Dividend Growth(5Y)24.1%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

45.11% of the earnings are spent on dividend by MB. This is a bit on the high side, but may be sustainable.
The dividend of MB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP45.11%
EPS Next 2Y7.17%
EPS Next 3Y6.02%
MB.MI Yearly Income VS Free CF VS DividendMB.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B
MB.MI Dividend Payout.MB.MI Dividend Payout, showing the Payout Ratio.MB.MI Dividend Payout.PayoutRetained Earnings

MEDIOBANCA SPA

BIT:MB (5/5/2025, 2:27:12 PM)

18.405

+0.2 (+1.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)05-08 2025-05-08
Inst Owners25.13%
Inst Owner ChangeN/A
Ins Owners9.98%
Ins Owner ChangeN/A
Market Cap15.34B
Analysts72.73
Price Target17.54 (-4.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.95%
Yearly Dividend1.38
Dividend Growth(5Y)24.1%
DP45.11%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.84%
Min EPS beat(2)-2.91%
Max EPS beat(2)4.58%
EPS beat(4)3
Avg EPS beat(4)4.6%
Min EPS beat(4)-2.91%
Max EPS beat(4)12.43%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.17%
Min Revenue beat(2)-3.66%
Max Revenue beat(2)6.01%
Revenue beat(4)2
Avg Revenue beat(4)0.89%
Min Revenue beat(4)-3.66%
Max Revenue beat(4)6.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.72%
PT rev (3m)6.59%
EPS NQ rev (1m)-3.75%
EPS NQ rev (3m)-3.27%
EPS NY rev (1m)0.29%
EPS NY rev (3m)0.87%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.63%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)0.26%
Valuation
Industry RankSector Rank
PE 11.43
Fwd PE 10.36
P/S 2.64
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)1.61
EY8.75%
EPS(NY)1.78
Fwd EY9.65%
FCF(TTM)-1.86
FCFYN/A
OCF(TTM)-1.73
OCFYN/A
SpS6.96
BVpS13.48
TBVpS12.21
PEG (NY)1.6
PEG (5Y)1.12
Profitability
Industry RankSector Rank
ROA 1.99%
ROE 17.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 34.24%
GM N/A
FCFM N/A
ROA(3y)1.14%
ROA(5y)1.03%
ROE(3y)9.67%
ROE(5y)8.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.77%
PM growth 5Y1.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 4.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC5.39%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)2.17%
Cap/Sales(5y)2.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.58%
EPS 3Y18.01%
EPS 5Y10.21%
EPS Q2Q%33.33%
EPS Next Y7.14%
EPS Next 2Y7.17%
EPS Next 3Y6.02%
EPS Next 5Y4.51%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y11.09%
Revenue growth 5Y7.64%
Sales Q2Q%13.4%
Revenue Next Year3.58%
Revenue Next 2Y3.9%
Revenue Next 3Y4.01%
Revenue Next 5Y2.63%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-125.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-123.7%
OCF growth 3YN/A
OCF growth 5Y102.52%